Each scientific advance in the fight against multiple sclerosis means further hope for patients and their families.
The recent designation by the FDD of tolebrutinib as a “breakthrough therapy” for multiple sclerosis is a new source of hope for the secondary progressive forms of the disease.
By targeting both innate and adaptive immunity, this treatment opens up new therapeutic possibilities and may well transform patient care in the future.
Manon, who lives with MS, will once again take part in the race with her team.
For the occasion, she has launched a delightful initiative: the Charcookies!
Homemade cookies, sold at €5 per bag to support the Foundation.
A big thank you to her — and to everyone who turns hope into action!
Reserve yours here: https://cookies.sclerose.be
This year, 137 dedicated runners will take on the challenge of the 20 km of Brussels in support of the Charcot Foundation.
A record number of participants… and a wonderful boost for multiple sclerosis research!
You can cheer them on by making a donation or sponsoring a runner:
https://support.sclerose.be/en-GB/projects
A major new project in the works: by this summer, the Charcot Foundation will launch a digital Knowledge Centre entirely dedicated to multiple sclerosis. Freely accessible, it will bring together reliable, clear, and up-to-date information on the mechanisms of the disease, its forms, treatments, and scientific advances.
A reference tool for everyone affected by MS, their loved ones, and healthcare professionals.
This year we are enormously pleased to lend our support to 8 new projects. We owe this to your donations and some exceptional patrons.
